A Phase Ii Randomised Controlled Trial Of An Early Tailored Cognitive Behavioural Therapy Based Intervention For Depression In Those Newly Diagnosed With Multiple Sclerosis (Action-Ms)

Grant number: 15-013 | Funding period: 2016 - 2020



Multiple sclerosis (MS) is an unpredictable, chronic neurological disease accompanied with high rates of depression and anxiety, particularly in the early stages of diagnosis. There is evidence to suggest that cognitive behavioural therapy (CBT) is effective for the treatment of depression amongst individuals with MS; however, there is a paucity of tailored CBT interventions designed to be offered in the newly diagnosed period. This trial is the first to assess the effectiveness and cost-effectiveness of a tailored CBT intervention compared to a supportive listening (SL) intervention amongst individuals with MS who are depressed.